We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

LivaNova plc (LIVN) Ord GBP1 (DI)

Sell:$50.51 Buy:$52.49 Change: $0.38 (0.74%)
NASDAQ:0.16%
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$50.51
Buy:$52.49
Change: $0.38 (0.74%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$50.51
Buy:$52.49
Change: $0.38 (0.74%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Contact details

Address:
20 Eastbourne Terrace
LONDON
W2 6LG
United Kingdom
Telephone:
+44 (20) 33250662
Website:
https://www.livanova.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LIVN
ISIN:
GB00BYMT0J19
Market cap:
$2.72 billion
Shares in issue:
54.30 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
Great Britain
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Vladimir Makatsaria
    Chief Executive Officer, Director
  • Alex Shvartsburg
    Chief Financial Officer
  • Stephanie Bolton
    President, Global Epilepsy
  • Michael Hutchinson
    Senior Vice President, Chief Legal Officer, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.